These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28740627)

  • 21. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.
    Sung KC; Ryan MC; Wilson AM
    Atherosclerosis; 2009 Apr; 203(2):581-6. PubMed ID: 18774133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
    Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
    Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents.
    Huang RC; Beilin LJ; Ayonrinde O; Mori TA; Olynyk JK; Burrows S; Hands B; Adams LA
    Hepatology; 2013 Oct; 58(4):1306-14. PubMed ID: 23703776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes.
    Kosmalski M; Kasznicki J; Drzewoski J
    Pol Arch Med Wewn; 2013; 123(9):436-42. PubMed ID: 23792440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.
    Wang L; Guo J; Lu J
    Oncotarget; 2016 Jun; 7(24):35632-35642. PubMed ID: 27248665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
    Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease.
    Ebrahimi S; Gargari BP; Aliasghari F; Asjodi F; Izadi A
    Int J Vitam Nutr Res; 2020 Jan; 90(1-2):95-102. PubMed ID: 30932777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients.
    Khodadoostan M; Shariatifar B; Motamedi N; Abdolahi H
    Adv Biomed Res; 2016; 5():40. PubMed ID: 27099853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Nonalcoholic Fatty Liver Disease and its Related Metabolic Risk Factors in Isfahan, Iran.
    Adibi A; Maleki S; Adibi P; Etminani R; Hovsepian S
    Adv Biomed Res; 2017; 6():47. PubMed ID: 28503502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease.
    Pastori D; Baratta F; Novo M; Cocomello N; Violi F; Angelico F; Del Ben M
    J Clin Med; 2018 Oct; 7(11):. PubMed ID: 30360566
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum α-fetoprotein levels in liver steatosis.
    Babalı A; Cakal E; Purnak T; Bıyıkoğlu I; Cakal B; Yüksel O; Köklü S
    Hepatol Int; 2009 Dec; 3(4):551-5. PubMed ID: 19890679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
    Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
    J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes.
    Sanyal D; Mukherjee P; Raychaudhuri M; Ghosh S; Mukherjee S; Chowdhury S
    Indian J Endocrinol Metab; 2015; 19(5):597-601. PubMed ID: 26425466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.